Cargando…

ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner

Background: N6-methyladenosine (m6A) is one of the most prevalent mRNA modifications in mammals, and it regulates the fate of modified RNA transcripts. In the current study, we aimed to elucidate the role of YTH m6A RNA-binding protein 1 (YTHDF1), a “reader” of m6A modification, in prostate cancer t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Peizhang, Shi, Yuanping, Gao, Dajun, Xu, Huan, Zou, Yun, Wang, Zhong, Li, Wenzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682537/ https://www.ncbi.nlm.nih.gov/pubmed/36439881 http://dx.doi.org/10.7150/ijbs.75063

Ejemplares similares

YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
por: Chen, Hengyu, et al.
Publicado: (2022)

YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
por: Liu, Xiangxiang, et al.
Publicado: (2020)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

YTHDF2 facilitates aggresome formation via UPF1 in an m(6)A-independent manner
por: Hwang, Hyun Jung, et al.
Publicado: (2023)

Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner
por: Liu, Xiangxiang, et al.
Publicado: (2022)

E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1
por: Li, Peizhang, et al.
Publicado: (2022)

The m(6)A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m(6)A-Dependent Manner
por: Chen, Xiao-Yu, et al.
Publicado: (2021)

Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination
por: Biswas, Ayan, et al.
Publicado: (2021)

A-Kinase Anchor Protein 95 Is Involved in ERK1/2–Elk-1 Signal Transduction in Colon Cancer
por: Kong, Xiangyu, et al.
Publicado: (2023)

YTHDF1 Negatively Regulates Treponema pallidum-Induced Inflammation in THP-1 Macrophages by Promoting SOCS3 Translation in an m6A-Dependent Manner
por: Li, Zhijia, et al.
Publicado: (2022)

Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015)

Polo-like kinase 1 promotes pulmonary hypertension
por: Chen, Rongrong, et al.
Publicado: (2023)

The balance of Polo-like kinase 1 in tumorigenesis
por: Lu, Lin-Yu, et al.
Publicado: (2009)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

Phosphorylation of β‐catenin Ser60 by polo‐like kinase 1 drives the completion of cytokinesis
por: Yu, Ji Eun, et al.
Publicado: (2021)

PBRM1 Cooperates with YTHDF2 to Control HIF-1α Protein Translation
por: Shmakova, Alena, et al.
Publicado: (2021)

YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner
por: Lin, Yuxiang, et al.
Publicado: (2022)

The Catalytic Subunit of DNA-Dependent Protein Kinase Coordinates with Polo-Like Kinase 1 to Facilitate Mitotic Entry()
por: Lee, Kyung-Jong, et al.
Publicado: (2015)

m(6)A facilitates YTHDF‐independent phase separation
por: Liu, Si‐Yu, et al.
Publicado: (2019)

m(6)A facilitates hippocampus-dependent learning and memory through Ythdf1
por: Shi, Hailing, et al.
Publicado: (2018)

Polo-like kinase-1 in DNA damage response
por: Hyun, Sun-Yi, et al.
Publicado: (2014)

Polo-like kinase 1 as target for cancer therapy
por: Weiß, Lily, et al.
Publicado: (2012)

Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain
por: Chen, Yunyu, et al.
Publicado: (2016)

The m(6)A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m(6)A dependent manner
por: Ke, Meng-Yun, et al.
Publicado: (2023)

YTHDF1 promotes mRNA degradation via YTHDF1‐AGO2 interaction and phase separation
por: Li, Jiong, et al.
Publicado: (2021)

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
por: Yun, Sang-Moon, et al.
Publicado: (2009)

A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018)

Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)

Enhanced polo-like kinase 1 expression in myelodysplastic syndromes
por: Min, Kyoung Il, et al.
Publicado: (2019)

Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe
por: Li, Jingjing, et al.
Publicado: (2015)

Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4(+) T cells ex vivo
por: Zhou, Dawei, et al.
Publicado: (2020)

Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1
por: Murugan, Ravichandran N., et al.
Publicado: (2013)

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)

Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
por: Song, Bing, et al.
Publicado: (2012)

H19 recruited N(6)-methyladenosine (m(6)A) reader YTHDF1 to promote SCARB1 translation and facilitate angiogenesis in gastric cancer
por: Bai, Rumeng, et al.
Publicado: (2023)

FTO-dependent m(6)A regulates muscle fiber remodeling in an NFATC1–YTHDF2 dependent manner
por: Wang, Wengang, et al.
Publicado: (2023)

MCC1019, a selective inhibitor of the Polo-box domain of Polo-like kinase 1 as novel, potent anticancer candidate
por: Abdelfatah, Sara, et al.
Publicado: (2019)

The m(6)A reader YTHDF1 regulates axon guidance through translational control of Robo3.1 expression
por: Zhuang, Mengru, et al.
Publicado: (2019)

Identification of polo‐like kinase 1 as a therapeutic target in murine lupus
por: Li, Yaxi, et al.
Publicado: (2022)

Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors
por: Zhao, Xue Zhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_169t74u8pithbvbcfj9vn000r1